"Ciprofloxacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum antimicrobial carboxyfluoroquinoline.
Descriptor ID |
D002939
|
MeSH Number(s) |
D03.633.100.810.835.322.186
|
Concept/Terms |
Ciprofloxacin Hydrochloride- Ciprofloxacin Hydrochloride
- Hydrochloride, Ciprofloxacin
- Ciprofloxacin Monohydrochloride Monohydrate
- Monohydrate, Ciprofloxacin Monohydrochloride
- Monohydrochloride Monohydrate, Ciprofloxacin
|
Below are MeSH descriptors whose meaning is more general than "Ciprofloxacin".
Below are MeSH descriptors whose meaning is more specific than "Ciprofloxacin".
This graph shows the total number of publications written about "Ciprofloxacin" by people in this website by year, and whether "Ciprofloxacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 1 | 2 |
1999 | 1 | 1 | 2 |
2000 | 1 | 1 | 2 |
2001 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ciprofloxacin" by people in Profiles.
-
The penetration of ciprofloxacin into human pancreatic and peripancreatic necroses in acute necrotizing pancreatitis. Infection. 2001 Dec; 29(6):326-31.
-
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2000 Nov; 44(11):3229-31.
-
Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment. J Antimicrob Chemother. 2000 Mar; 45(3):353-6.
-
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS Immunol Med Microbiol. 1999 Dec; 26(3-4):281-7.
-
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Antimicrob Agents Chemother. 1999 Aug; 43(8):2051-5.
-
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob Agents Chemother. 1998 May; 42(5):1249-52.
-
Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus. J Antimicrob Chemother. 1998 Apr; 41(4):481-4.